Table 2.

Previously reported mpox cases in pregnant individuals with known gestational outcomes during the 2022–2023 outbreak.

Author/year	Manuscript type	Clinical course
Sampson et al., 2023 [10]	Case report (n = 1)	20-year-old female with genital ulcer positive for mpox virus and herpes simplex virus at 31 weeks’ gestation treated with tecovirimat (600 milligrams twice daily for 14 days). Underwent uncomplicated elective induction at 39 weeks 2 days with delivery of healthy neonate. Histopathologic examination of placenta was normal.
Oakley et al., 2023 [11]	Case series (n = 3)	3/23 patients with mpox during pregnancy in the case series had known gestational outcomes. One patient experienced spontaneous abortion at 11 weeks’ gestation and two patients had full-term uncomplicated deliveries. Further details are not reported.